Novozymes Cash Flow from Investing Activities 2011-2023 | NVZMY

Novozymes annual/quarterly cash flow from investing activities history and growth rate from 2011 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Novozymes cash flow from investing activities for the quarter ending December 31, 2023 was $-0.310B, a 18.14% decline year-over-year.
  • Novozymes cash flow from investing activities for the twelve months ending December 31, 2023 was $-0.734B, a 15.84% decline year-over-year.
  • Novozymes annual cash flow from investing activities for 2023 was $-0.31B, a 18.14% decline from 2022.
  • Novozymes annual cash flow from investing activities for 2022 was $-0.378B, a 13.43% decline from 2021.
  • Novozymes annual cash flow from investing activities for 2021 was $-0.437B, a 87.19% increase from 2020.
Novozymes Annual Cash Flow Investing
(Millions of US $)
2023 $-310
2022 $-378
2021 $-437
2020 $-233
2019 $-84
2018 $-220
2017 $-253
2016 $-200
2015 $-187
2014 $-55
2013 $-249
2012 $-330
2011 $
2010 $
Sector Industry Market Cap Revenue
Basic Materials Chemicals - Specialty $28.037B $2.598B
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
Stock Name Country Market Cap PE Ratio
Linde (LIN) United Kingdom $204.855B 29.31
Ecolab (ECL) United States $64.576B 39.88
Givaudan SA (GVDNY) Switzerland $42.484B 0.00
PPG Industries (PPG) United States $29.817B 16.49
Celanese (CE) United States $16.204B 16.50
Croda (COIHY) United Kingdom $8.007B 0.00
Axalta Coating Systems (AXTA) United States $7.517B 19.92
Element Solutions (ESI) United States $5.749B 17.86
Valvoline (VVV) United States $5.095B 26.72
NewMarket (NEU) United States $5.028B 12.61
Ashland (ASH) United States $4.929B 29.26
Balchem (BCPC) United States $4.852B 42.27
Arcadium Lithium (ALTM) United States $4.688B 3.23
H B Fuller (FUL) United States $4.216B 19.44
Nissan Chemical (NNCHY) Japan $4.049B 16.30
CSW Industrials (CSWI) United States $3.979B 36.56
Orbia Advance, S.A.B De C.V (MXCHY) Mexico $3.528B 0.00
Quaker Houghton (KWR) United States $3.197B 22.64
Sensient Technologies (SXT) United States $3.146B 25.97
Minerals Technologies (MTX) United States $2.717B 15.13
Hawkins (HWKN) United States $1.787B 23.80
Ingevity (NGVT) United States $1.728B 14.20
DAQO New Energy (DQ) China $1.405B 9.99
Orion S.A (OEC) United States $1.401B 14.05
ELEMENTIS (ELMTY) United Kingdom $1.104B 0.00
Green Plains (GPRE) United States $1.099B 0.00
Perimeter Solutions, SA (PRM) Luxembourg $1.052B 0.00
Mativ Holdings (MATV) United States $0.958B 18.19
Huabao Holdings (HUIHY) Hong Kong, SAR China $0.943B 0.00
Westlake Chemical Partners LP (WLKP) United States $0.791B 14.57
AdvanSix (ASIX) United States $0.599B 0.00
Westaim (WEDXF) Canada $0.382B 3.68
NL Industries (NL) United States $0.355B 30.29
American Vanguard (AVD) United States $0.250B 30.83
5E Advanced Materials (FEAM) United States $0.068B 0.00